Uterine Fibroid Drugs Market Set to Reach US$ 12.8 Billion by 2035 | Astute Analytica

Oral GnRH antagonists like Myfembree, Yselty, and Oriahnn now lead uterine fibroid treatment, offering high efficacy in ...